These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11834380)

  • 1. Treatment of clinical stage I germ cell tumors.
    Chang SS; Roth B
    Urology; 2002 Feb; 59(2):173-9. PubMed ID: 11834380
    [No Abstract]   [Full Text] [Related]  

  • 2. Testicular cancer: when less is more.
    Pagliaro LC
    Curr Oncol Rep; 2010 Jul; 12(4):271-7. PubMed ID: 20443156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current procedure for treating testicular germ-cell tumors].
    Tiuliandin SA; Figurin KM; Garin AM
    Urol Nefrol (Mosk); 1995; (6):40-4. PubMed ID: 8686125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
    Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
    Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should manage germ cell tumours of the testis?
    Mead GM
    BJU Int; 1999 Jul; 84(1):61-7. PubMed ID: 10444126
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cured of testicular cancer].
    Théodore C
    Bull Cancer; 2003 Apr; 90(4):327-31. PubMed ID: 12801816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCCN practice guidelines for testicular cancer. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):417-62. PubMed ID: 10028524
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of adjuvant treatment in low-stage germ cell testicular tumors.
    Pizzocaro G; Salvioni R; Nicolai N
    Eur Urol; 1995; 28(4):267-72. PubMed ID: 8575492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection.
    von Amsberg G; Hamilton R; Papachristofilou A
    Oncol Res Treat; 2018; 41(6):360-363. PubMed ID: 29763926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of extensiveness of testicular germinoma on the choice of a treatment regimen].
    Gorelov AI; Bogdanova EO; Komiakova BK
    Vopr Onkol; 2003; 49(4):455-8. PubMed ID: 14569936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer.
    Daneshmand S
    Curr Opin Urol; 2020 Mar; 30(2):234. PubMed ID: 31922969
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of stage I germ cell tumors of the testis].
    Santomé Couto L; Tabernero Caturla JM; Villavicencio Mavrich H; Valentí Moreno V
    Arch Esp Urol; 2000; 53(6):474-86. PubMed ID: 11002515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
    Sheinfeld J
    Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
    [No Abstract]   [Full Text] [Related]  

  • 14. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
    Cooper DE; L'esperance JO; Christman MS; Auge BK
    J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
    Feldman DR
    Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the Management of Low-stage Seminoma.
    Xia L; Daneshmand S
    Urol Clin North Am; 2024 Aug; 51(3):377-385. PubMed ID: 38925740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
    Pedraza AM; Stephenson AJ
    Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy.
    Kisbenedek L; Bodrogi I; Szeldeli P; Baki M; Tenke P; Horti J
    Int Urol Nephrol; 1995; 27(3):325-9. PubMed ID: 7591598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissection.
    Rice KR; Beck SD; Bihrle R; Cary KC; Einhorn LH; Foster RS
    J Urol; 2014 Nov; 192(5):1397-402. PubMed ID: 24813309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of low-stage nonseminomatous germ cell tumors of the testis.
    Steele GS; Richie JP
    Compr Ther; 2000; 26(3):210-9. PubMed ID: 10984827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.